Notes
Slide Show
Outline
1
WOLFRAM SYNDROME IN 2 SIBLINGS
  • D.S.Casper, MD
  • Edward Harkness Eye Institute
2
Patient History
  • A 21 yo Hispanic male (Pt A) and his 19 yo sister (Pt B) were seen for complaints of poor vision.
3
Past Medical History
  • The two patients have known diabetes mellitus (DM), diabetes insipidus (DI), optic atrophy (OA), and the boy shows some mild deafness.
  • They arrived in this country from the Dominican Republic in late 1994.
  • They were both diagnosed with DM Type 1 prior to the age of 4 and are both on insulin.
4
PMH – Patient A
  • Within days of their arrival here, Pt A. was admitted to the hospital with a diagnosis of Diabetic Ketoacidosis and dehydration; his blood glucose was 665.
  • During the hospitalizations Optic Nerve atrophy was first noted in Pt A at age 12; and diabetes insipidus was noted at age 18.
  • No other pathologies were noted


5
PMH – Patient B
  • Pt B. was admitted within weeks of her arrival with recurrent hypoglycemia.
  • Pt B. was admitted again at the same hospital at age 14 for poorly controlled DM with worsening polyuria and polydipsia.
  • In view of her brother’s diagnoses, she was evaluated at that time by our service, and found to have optic atrophy as well.
  • Studies to determine whether she had DI were inconclusive, although it was felt that she probably had some minimal DI at that time.
  • Pt. B. was also found to have peripheral neuropathy, for which she was started on gabapentin.


6
Clinical / Ocular Examination Patient A
  • Visual acuity of CF @ 6  OD and HM at 1 foot OS with poor projection.
  • Pupils were large, and only barely reactive
  • APD was not appreciated.
  • The remainder of the examination was notable for bilateral optic atrophy (see Fig 1 in the next slide) without evidence of diabetic retinal changes.


  • MRI in the year 2000 confirmed the finding of bilateral optic hypoplasia with thinned optic chiasm. A repeat scan this year showed no interval change.
7
Figure 1
8
Patient B
  • Visual acuity was found to be 20/150 bilaterally.
  • Pupils were also large, but were round and reactive OU without APD.
  • Funduscopic examination revealed bilateral optic atrophy without diabetic changes. (see fig 2 in the next slide)


  • MRI study in the year 2000 showed bilateral small optic nerves.


9
Figure 2
10
DISCUSSION
  • This progressive neurodegenerative disorder, also known as DIDMOAD (DI = Diabetes Insipidus; DM = Diabetes Mellitus; OA = Optic Atrophy; D = Deafness)
  • It is named after the physician who first described 4 siblings with juvenile diabetes mellitus and
    optic atrophy in 1938.
  • Wolfram1s Syndrome is the inherited association of juvenile-onset insulin-dependent diabetes with progressive optic atrophy.
  • The estimated prevalence in North America is approximately 1/100,000.
  • Pathogenesis: unknown.
11
"A nuclear gene,"
  • A nuclear gene, WFS1/woframin, has been identified, as has autosomal recessive inheritance.
    A high frequency of the HLA-DR2 antigen has been noted in these patients.
  • Mutation analysis of the WFS1 gene (mapped to chromosome 4p16.1) in Wolfram patients has shown mutations in 90% of patients.
  • A second locus (WFS2) has been implicated at 4q, and it has been suggested that a minority of patients may harbor a mitochondrial genome deletion.
12
Clinical Characteristics
  • Ocular manifestation typically present in the first decade of life with diabetes mellitus followed by optic atrophy
  • Visual evoked potentials usually show reduced
    amplitude to both flash and pattern stimulation.
  • Diabetes insipidus and sensorineural deafness in the second decade
  • Dilated renal outflow tracts early in the third decade
  • Multiple neurologic abnormalities develop early in the fourth decade.


13
Cont’
  • Most patients eventually develop all major aspects of the disease.
  • In addition, short stature, hypogonadism, psychiatric disorders (depression, psychosis, aggression and dementia)
  • Grand mal seizures are associated
    with the more well-known pathologic features of this syndrome.
  • Death typically occurs prematurely (median age at death ~ 30 yrs), usually from respiratory
    failure secondary to brainstem atrophy.